{"count":11,"next":null,"previous":null,"results":[{"url":"https://lda.gov/api/v1/filings/cca9f234-482c-4127-b45b-0fc05626bff6/","filing_uuid":"cca9f234-482c-4127-b45b-0fc05626bff6","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/cca9f234-482c-4127-b45b-0fc05626bff6/print/","filing_document_content_type":"text/html","income":null,"expenses":"85552.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Shari Erickson","dt_posted":"2026-07-15T14:55:49-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"25 Massachusetts Avenue, NW, Suite 700","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":2002,"url":"https://lda.gov/api/v1/registrants/2002/","house_registrant_id":32190,"name":"AMERICAN COLLEGE OF PHYSICIANS","description":null,"address_1":"25 Massachusetts Avenue, NW, Suite 700","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GEORGE LYONS JR.","contact_telephone":"+1 202-261-4531","dt_updated":"2026-07-13T17:53:37.650943-04:00"},"client":{"id":102673,"url":"https://lda.gov/api/v1/clients/102673/","client_id":12,"name":"AMERICAN COLLEGE OF PHYSICIANS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ACPs 2026 Second Quarter Lobbying Disclosure Report Medicare Payments to Physicians: Met with House Doctors Caucus about Medicare payment reform, including draft language to be included in bills for a Medicare Economic Index inflationary updated to the physician fee schedule for physician practices. Supported and urged Congress to pass H.R. 8163, the Provider Reimbursement Stability Act, to enhance Medicare reimbursement stability for physicians by modernizing the Medicare Physician Fee Schedule. The Provider Reimbursement Stability Act of 2026. H.R. 8163 would raise the budget neutrality threshold from $20 million to $54.3 million and would use cumulative increases in the Medicare Economic Index (MEI) to update the threshold every 5 years. ACP supported the Medicare Physician Data-Drive Performance Payment System Act of 2026. This critical legislation seeks to modernize Medicare payments by reducing administrative burdens, improving patient care, and supporting small/rural practices through a more practical, data-driven approach. Dr. William Fox, Chair Emeritus of ACPs Board of Regents, testified before the House Energy and Commerce Committees Health Subcommittee on policy reforms to improve the Medicare Physician Fee Schedule and the Medicare Access and CHIP Reauthorization Act (MACRA) on behalf of ACP. Support Value-Based Care: Urged reintroduction and support of the Value in Health Care Act of 2024. The bill provides a multi-year commitment to reforming care delivery by extending MACRAs 5 percent advanced alternative payment models (APM) incentives that expired at the end of 2024. ACP supported the Preserving Patient Access to Accountable Care Act which aligns with Colleges policy to support the transition to value-based payments through alternative payment models (APMs) that can accommodate a wide range of specialties, practice sizes, and unique patient populations. ACP supported this legislation as it would extend the incentive payments for qualifying physicians and other clinicians to participate in Medicare advanced APMs through payment year 2027 at an increased amount of 3.53 percent and would freeze the scheduled increase in qualifying thresholds. Pricing Transparency/Consolidation: Provided comments to the House Energy and Commerce Committees markup, which includes the Lower Cost, More Transparency Act, H.R. 9393, and the Improving Seniors Timely Access to Care Act, H.R. 3514. The two bills would enhance price transparency across health care entities and streamline unnecessary administrative burden, respectively. ACP also supported several policies included in bills slated for markup that would reform Medicare Advantage practices to ensure accountability and safeguard market competition. ACP strongly supports pricing transparency in health care. ACP supported the passage of the Lower Costs, More Transparency Act, which passed the House in the 118th Congress, and we continue to support its reintroduction and passage in this Congress under H.R. 9393. ACP supported provisions within the Medicare Advantage Cost Transparency Act, H.R. 9392, led by Ranking Member DeGette and Dr. Joyce, which would provide greater oversight by requiring that Medicare Advantage (MA) plans report to the Centers for Medicare & Medicaid Services (CMS) on encounter data, including the allowed amount that a plan agreed to pay for a service in total and the total out-of-pocket costs the patient pays for a service. The College has repeatedly voiced support for the Improving Seniors' Timely Access to Care Act, led by Reps. Kelly and DelBene, which would protect patients from unnecessary delays in care and reduce administrative burden on physicians by streamlining MAs prior authorization approval processes. We urge Congress to pass H.R. 3514 to ensure that our patients will get the care they need, when they need it most. FY2026 Appropriations/Agency Restructuring: For FY2027, ACP is urged appropriations committees that funding be either maintained or increased for the following proven programs: 1) Health Resources Services Administration (HRSA), $10.5 billion, including: 2) Health Workforce, National Health Service Corps (NHSC), $915.6 million in total program funding; 3) Primary Care Training and Enhancement (PCTE), $71 million; 4) Title X Family Planning Program, $390 million; 5) Agency for Healthcare Research and Quality (AHRQ), $500 million; 6) Centers for Disease Control and Prevention (CDC) Injury Prevention and Control, $11.6 billion, including: 7) Firearm Injury and Mortality Prevention Research, $35 million; 8) Chronic Disease Prevention and Health Promotion, Social Determinants of Health, $100 million; 9) National Institutes of Health (NIH), $51.3 billion, including: 10) Office of the Director, Firearms Research, $25 million; 11) Centers for Medicare and Medicaid Services (CMS) and Government Accountability Office (GAO); and 12) Report language to ensure primary care physicians are receiving Medicare physician revaluations. We urged Congress to include report language in the FY2026 Labor HHS appropriations bill to direct the GAO to conduct a study encompassing the last decade of CMS estimates of new and revised code utilizations. ACP believes CMS has overestimated utilizations, thus adversely affecting available funds in the Medicare physician fee schedule for other code usage. While the House and Senate bills included language, we prefer the stronger House version language and hope Congress will pass the FY26 Labor HHS bills. Also urged Congress to include report language in the FY2027 Labor HHS appropriations bill directing a study on extent G2211 add on codes and increases in fee schedule for primary care are being retained by hiring entities (hospitals, ACOs, private equity) versus the physicians. ACP urged appropriators to provide $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health (NIH), and $1 million for the National Institute of Justice (NIJ) to conduct public health research into firearm morbidity and mortality prevention. Primary Care and the Physician Workforce: ACP urged Congress to support the Resident Physician Shortage Reduction Act of 2025 (S. 2439/ H.R. 4731), which would increase the number of Medicare supported direct graduate medical education (DGME) and indirect medical education (IME) positions by 14,000 over seven years. ACP supported the Conrad State 30 and Physician Access Reauthorization Act, S. 709 and H.R. 1585, to allow states to sponsor foreign-trained physicians to work in medically underserved areas in exchange for a waiver of the physicians' two-year foreign residence requirement. We supported the Resident Education Deferred Interest (REDI) Act (S 942/HR 2028) that, if passed, will allow borrowers to qualify for interest-free deferment on their student loans while serving in a medical or dental internship or residency program. ACP supported legislation for the H-1Bs for Physicians and Healthcare Workforce Act, H.R. 7961. The bill's primary goal is to exempt healthcare professionals from a $100,000 H-1B visa filing fee. Scope of Practice: ACP provided comments urging the House Ways and Means Committee during markup to oppose the Equitable Community Access to Pharmacist Services Act, which would expand Medicare coverage to permanently include select services provided by a pharmacist. Expand Patient Access: We urged Congress to reintroduce and pass the Chronic Care Management Improvement Act. This legislation would have removed the cost sharing requirement for patients to access chronic care management services. We also support allowing the physician that performs chronic care management services to waive the requirement that the patient pay the 20 percent coinsurance fee associated with this service. We urged Congress to protect the public health infrastructure, recognize evidence-based science and preserve healthcare agency staffing to inform and protect the public from infectious disease and other health emergencies. Incidences of previously well-controlled, vaccine-preventable diseases, such as pertussis (whooping cough) and measles, are increasing in the United States. Vaccines are vital to our ability to prevent diseases that threaten public health, including novel diseases and future pandemics. We urged Congress to utilize the best possible scientific evidence to guide public health legislation. It is critical that public health leaders support evidence-based medicine, including the use of vaccines and other effective public health strategies that protect the public. ACP conducted a Hill Briefing on using scientifically driven, evidenced-based vaccines. Clinical Labs: Supported the provision in H.R. 6366 that would delay payment reductions and data reporting periods for the Clinical Laboratory Fee Schedule under the Protecting Access to Medicare Act (PAMA). Legislation could improve patient access to laboratory tests used to diagnose, monitor, prevent, and manage diseases for Medicare beneficiaries. Prescription Drug Reform: Supported the Capping Prescription Costs Act, introduced by Senator Raphael Warnock. The legislation would lower prescription drug costs for millions of Americans by placing annual caps on out-of-pocket costs for prescription drugs at $2,000 for individuals and $4,000 for families with private insurance. Supported bipartisan Drug-price Transparency for Consumers (DTC) Act, a bill that would require price disclosures on advertisements for prescription drugs in order to empower patients and reduce Americans colossal spending on medications. The bill was introduced by Senators Dick Durbin and Chuck Grassley. ACP also supported the Saving Seniors Money on Prescriptions Act, H.R. 950, which aims to drive down the rising costs of prescription drugs for patients on Medicare by improving price transparency in Pharmacy Benefit Managers (PBMs) business practices. Urged Congress to reintroduce and pass: 1) the Lowering Drug Costs for American Families Act, to expand the number of prescription drugs which Medicare can negotiate under the Inflation Reduction Act from 20 to 50 starting in 2029; 2) the Medicare PBM Accountability Act, legislation aimed at lowering the costs of prescription drugs for seniors covered by Medicare Part D and Medicare Advantage plans; 3) the Increasing Access to Biosimilars Act of 2023, legislation which would encourage adoption of biosimilars in Medicare and improve biosimilar accessibility, by establishing a new pilot program - a voluntary, shared savings demonstration program - for providers of biosimilars in Medicare Part B; 4) the Cutting Copays Act, legislation which would eliminate cost-sharing for generic drugs for LIS beneficiaries, helping to incentivize the use of generic drugs; and the Drug Shortage Prevention Act of 2023, which would require that manufacturers of over-the-counter and prescription drugs notify Food & Drug Administration when they are unlikely to meet demand. ACP supported legislation, Drug-price Transparency for Consumers (DTC) Act, by Senators. Durbin and Grassley that requires Direct-to-Consumer advertisements for prescription drugs and biological products paid for by Medicare and Medicaid to include the list price or Wholesale Acquisition Cost (WAC) for a 30-month supply-which is the price set by manufacturers (and which is paid by uninsured patients, as well as the 50 percent of patients with high-deductible plans).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53637,"prefix":null,"prefix_display":null,"first_name":"SHARI","nickname":null,"middle_name":null,"last_name":"ERICKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141127,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PUGACH","suffix":null,"suffix_display":null},"covered_position":null,"new":true},{"lobbyist":{"id":146685,"prefix":null,"prefix_display":null,"first_name":"VY","nickname":null,"middle_name":null,"last_name":"OXMAN","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":9,"name":"President of the U.S."},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/3bb90e7a-823a-443d-9ec7-a77f454d7382/","filing_uuid":"3bb90e7a-823a-443d-9ec7-a77f454d7382","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/3bb90e7a-823a-443d-9ec7-a77f454d7382/print/","filing_document_content_type":"text/html","income":null,"expenses":"391703.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"George Lyons, Jr.","dt_posted":"2026-07-15T15:21:05-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"25 Massachusetts Avenue, NW, Suite 700","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":311451,"url":"https://lda.gov/api/v1/registrants/311451/","house_registrant_id":40002,"name":"AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC.","description":"Healthcare","address_1":"25 Massachusetts Avenue NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GEORGE LYONS JR.","contact_telephone":"+1 202-261-4531","dt_updated":"2026-07-13T14:54:36.424626-04:00"},"client":{"id":183820,"url":"https://lda.gov/api/v1/clients/183820/","client_id":12,"name":"AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1999-12-30"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ACPs 2026 Second Quarter Lobbying Disclosure Report Medicare Payments to Physicians: Met with House Doctors Caucus about Medicare payment reform, including draft language to be included in bills for a Medicare Economic Index inflationary updated to the physician fee schedule for physician practices. Supported and urged Congress to pass H.R. 8163, the Provider Reimbursement Stability Act, to enhance Medicare reimbursement stability for physicians by modernizing the Medicare Physician Fee Schedule. The Provider Reimbursement Stability Act of 2026. H.R. 8163 would raise the budget neutrality threshold from $20 million to $54.3 million and would use cumulative increases in the Medicare Economic Index (MEI) to update the threshold every 5 years. ACP supported the Medicare Physician Data-Drive Performance Payment System Act of 2026. This critical legislation seeks to modernize Medicare payments by reducing administrative burdens, improving patient care, and supporting small/rural practices through a more practical, data-driven approach. Dr. William Fox, Chair Emeritus of ACPs Board of Regents, testified before the House Energy and Commerce Committees Health Subcommittee on policy reforms to improve the Medicare Physician Fee Schedule and the Medicare Access and CHIP Reauthorization Act (MACRA) on behalf of ACP. Support Value-Based Care: Urged reintroduction and support of the Value in Health Care Act of 2024. The bill provides a multi-year commitment to reforming care delivery by extending MACRAs 5 percent advanced alternative payment models (APM) incentives that expired at the end of 2024. ACP supported the Preserving Patient Access to Accountable Care Act which aligns with Colleges policy to support the transition to value-based payments through alternative payment models (APMs) that can accommodate a wide range of specialties, practice sizes, and unique patient populations. ACP supported this legislation as it would extend the incentive payments for qualifying physicians and other clinicians to participate in Medicare advanced APMs through payment year 2027 at an increased amount of 3.53 percent and would freeze the scheduled increase in qualifying thresholds. Pricing Transparency/Consolidation: Provided comments to the House Energy and Commerce Committees markup, which includes the Lower Cost, More Transparency Act, H.R. 9393, and the Improving Seniors Timely Access to Care Act, H.R. 3514. The two bills would enhance price transparency across health care entities and streamline unnecessary administrative burden, respectively. ACP also supported several policies included in bills slated for markup that would reform Medicare Advantage practices to ensure accountability and safeguard market competition. ACP strongly supports pricing transparency in health care. ACP supported the passage of the Lower Costs, More Transparency Act, which passed the House in the 118th Congress, and we continue to support its reintroduction and passage in this Congress under H.R. 9393. ACP supported provisions within the Medicare Advantage Cost Transparency Act, H.R. 9392, led by Ranking Member DeGette and Dr. Joyce, which would provide greater oversight by requiring that Medicare Advantage (MA) plans report to the Centers for Medicare & Medicaid Services (CMS) on encounter data, including the allowed amount that a plan agreed to pay for a service in total and the total out-of-pocket costs the patient pays for a service. The College has repeatedly voiced support for the Improving Seniors' Timely Access to Care Act, led by Reps. Kelly and DelBene, which would protect patients from unnecessary delays in care and reduce administrative burden on physicians by streamlining MAs prior authorization approval processes. We urge Congress to pass H.R. 3514 to ensure that our patients will get the care they need, when they need it most. FY2026 Appropriations/Agency Restructuring: For FY2027, ACP is urged appropriations committees that funding be either maintained or increased for the following proven programs: 1) Health Resources Services Administration (HRSA), $10.5 billion, including: 2) Health Workforce, National Health Service Corps (NHSC), $915.6 million in total program funding; 3) Primary Care Training and Enhancement (PCTE), $71 million; 4) Title X Family Planning Program, $390 million; 5) Agency for Healthcare Research and Quality (AHRQ), $500 million; 6) Centers for Disease Control and Prevention (CDC) Injury Prevention and Control, $11.6 billion, including: 7) Firearm Injury and Mortality Prevention Research, $35 million; 8) Chronic Disease Prevention and Health Promotion, Social Determinants of Health, $100 million; 9) National Institutes of Health (NIH), $51.3 billion, including: 10) Office of the Director, Firearms Research, $25 million; 11) Centers for Medicare and Medicaid Services (CMS) and Government Accountability Office (GAO); and 12) Report language to ensure primary care physicians are receiving Medicare physician revaluations. We urged Congress to include report language in the FY2026 Labor HHS appropriations bill to direct the GAO to conduct a study encompassing the last decade of CMS estimates of new and revised code utilizations. ACP believes CMS has overestimated utilizations, thus adversely affecting available funds in the Medicare physician fee schedule for other code usage. While the House and Senate bills included language, we prefer the stronger House version language and hope Congress will pass the FY26 Labor HHS bills. Also urged Congress to include report language in the FY2027 Labor HHS appropriations bill directing a study on extent G2211 add on codes and increases in fee schedule for primary care are being retained by hiring entities (hospitals, ACOs, private equity) versus the physicians. ACP urged appropriators to provide $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health (NIH), and $1 million for the National Institute of Justice (NIJ) to conduct public health research into firearm morbidity and mortality prevention. Primary Care and the Physician Workforce: ACP urged Congress to support the Resident Physician Shortage Reduction Act of 2025 (S. 2439/ H.R. 4731), which would increase the number of Medicare supported direct graduate medical education (DGME) and indirect medical education (IME) positions by 14,000 over seven years. ACP supported the Conrad State 30 and Physician Access Reauthorization Act, S. 709 and H.R. 1585, to allow states to sponsor foreign-trained physicians to work in medically underserved areas in exchange for a waiver of the physicians' two-year foreign residence requirement. We supported the Resident Education Deferred Interest (REDI) Act (S 942/HR 2028) that, if passed, will allow borrowers to qualify for interest-free deferment on their student loans while serving in a medical or dental internship or residency program. ACP supported legislation for the H-1Bs for Physicians and Healthcare Workforce Act, H.R. 7961. The bill's primary goal is to exempt healthcare professionals from a $100,000 H-1B visa filing fee. Scope of Practice: ACP provided comments urging the House Ways and Means Committee during markup to oppose the Equitable Community Access to Pharmacist Services Act, which would expand Medicare coverage to permanently include select services provided by a pharmacist. Expand Patient Access: We urged Congress to reintroduce and pass the Chronic Care Management Improvement Act. This legislation would have removed the cost sharing requirement for patients to access chronic care management services. We also support allowing the physician that performs chronic care management services to waive the requirement that the patient pay the 20 percent coinsurance fee associated with this service. We urged Congress to protect the public health infrastructure, recognize evidence-based science and preserve healthcare agency staffing to inform and protect the public from infectious disease and other health emergencies. Incidences of previously well-controlled, vaccine-preventable diseases, such as pertussis (whooping cough) and measles, are increasing in the United States. Vaccines are vital to our ability to prevent diseases that threaten public health, including novel diseases and future pandemics. We urged Congress to utilize the best possible scientific evidence to guide public health legislation. It is critical that public health leaders support evidence-based medicine, including the use of vaccines and other effective public health strategies that protect the public. ACP conducted a Hill Briefing on using scientifically driven, evidenced-based vaccines. Clinical Labs: Supported the provision in H.R. 6366 that would delay payment reductions and data reporting periods for the Clinical Laboratory Fee Schedule under the Protecting Access to Medicare Act (PAMA). Legislation could improve patient access to laboratory tests used to diagnose, monitor, prevent, and manage diseases for Medicare beneficiaries. Prescription Drug Reform: Supported the Capping Prescription Costs Act, introduced by Senator Raphael Warnock. The legislation would lower prescription drug costs for millions of Americans by placing annual caps on out-of-pocket costs for prescription drugs at $2,000 for individuals and $4,000 for families with private insurance. Supported bipartisan Drug-price Transparency for Consumers (DTC) Act, a bill that would require price disclosures on advertisements for prescription drugs in order to empower patients and reduce Americans colossal spending on medications. The bill was introduced by Senators Dick Durbin and Chuck Grassley. ACP also supported the Saving Seniors Money on Prescriptions Act, H.R. 950, which aims to drive down the rising costs of prescription drugs for patients on Medicare by improving price transparency in Pharmacy Benefit Managers (PBMs) business practices. Urged Congress to reintroduce and pass: 1) the Lowering Drug Costs for American Families Act, to expand the number of prescription drugs which Medicare can negotiate under the Inflation Reduction Act from 20 to 50 starting in 2029; 2) the Medicare PBM Accountability Act, legislation aimed at lowering the costs of prescription drugs for seniors covered by Medicare Part D and Medicare Advantage plans; 3) the Increasing Access to Biosimilars Act of 2023, legislation which would encourage adoption of biosimilars in Medicare and improve biosimilar accessibility, by establishing a new pilot program - a voluntary, shared savings demonstration program - for providers of biosimilars in Medicare Part B; 4) the Cutting Copays Act, legislation which would eliminate cost-sharing for generic drugs for LIS beneficiaries, helping to incentivize the use of generic drugs; and the Drug Shortage Prevention Act of 2023, which would require that manufacturers of over-the-counter and prescription drugs notify Food & Drug Administration when they are unlikely to meet demand. ACP supported legislation, Drug-price Transparency for Consumers (DTC) Act, by Senators. Durbin and Grassley that requires Direct-to-Consumer advertisements for prescription drugs and biological products paid for by Medicare and Medicaid to include the list price or Wholesale Acquisition Cost (WAC) for a 30-month supply-which is the price set by manufacturers (and which is paid by uninsured patients, as well as the 50 percent of patients with high-deductible plans).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":37837,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BUCKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":60177,"prefix":null,"prefix_display":null,"first_name":"JARED","nickname":null,"middle_name":null,"last_name":"FROST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":40417,"prefix":null,"prefix_display":null,"first_name":"SHUAN","nickname":null,"middle_name":null,"last_name":"TOMLINSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":104508,"prefix":null,"prefix_display":null,"first_name":"GEORGE","nickname":null,"middle_name":null,"last_name":"LYONS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":9,"name":"President of the U.S."},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/d4641a33-7e4f-49a2-b370-8b52bb711f94/","filing_uuid":"d4641a33-7e4f-49a2-b370-8b52bb711f94","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/d4641a33-7e4f-49a2-b370-8b52bb711f94/print/","filing_document_content_type":"text/html","income":null,"expenses":"410000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Chris Long","dt_posted":"2026-07-20T16:38:47-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1425 K Street NW","registrant_address_2":"Suite 700","registrant_different_address":true,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401104493,"url":"https://lda.gov/api/v1/registrants/401104493/","house_registrant_id":null,"name":"BETTER MEDICARE ALLIANCE, INC.","description":"Nonprofit supporting Medicare Advantage.","address_1":"1425 K Street NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRIS LONG","contact_telephone":"+1 202-735-0037","dt_updated":"2026-07-30T11:39:36.929227-04:00"},"client":{"id":201949,"url":"https://lda.gov/api/v1/clients/201949/","client_id":12,"name":"BETTER MEDICARE ALLIANCE, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-05-30"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Diversifying health care workforce issues Payer provider directories and accuracy of information issues General Telemedicine Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142623,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"M.","last_name":"LONG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146278,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"NORD MALLARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149563,"prefix":null,"prefix_display":null,"first_name":"MACKENZIE","nickname":null,"middle_name":null,"last_name":"BANKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S.1105--No Unreasonable Payments, Coding, or Diagnoses for the Elderly (No UPCODE) Act--An act to improve the way Medicare Advantage plans assess patients health risks and reduce overpayments for care. H.R 4093--Apples to Apples--An act to require the Secretary of Health and Human Services to publish information on expenditures under the Medicare program, and for other purposes. S. 2625--Independent BROKERS TIME Act of 2025--An Act to carry out certain activities relating to the regulation of independent agents and brokers and third-party marketing organizations under parts C and D of the Medicare program, and for other purposes. H.R. 5243--Increase data transparency for supplemental benefits under Medicare Advantage--An Act to increase data transparency around Medicare Advantage supplemental benefits for seniors. S. 2793--Require Medicare Advantage plans to cover items and services furnished by certain essential community providers within a service area--An act to add an Essential Community Provider (ECP) requirement to Medicare Advantage networks. H.R. 5454--Medicare Advantage Prompt Pay Act--An act to improve Medicare Advantages (MA) billing practices, offer certainty health care providers who contract with MA plans, and ensure that seniors arent stuck with unfair, confusing, or delayed bills after receiving critical care. H.R. 5746--Addressing Whole Health in Medicare Advantage Act--Supplemental Benefits for chronically ill enrollees S. 3573--Medicare Advantage Supplemental Benefits Transparency Act--Improving Supplemental Benefits for MA beneficiaries H.R. 3514--To amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans--Prior Authorization in Medicare Advantage S 1816--A bill to amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans--Prior Authorization in Medicare Advantage H.R. 9393--Lower Costs, More Transparency Act of 2026--Promotes price transparency across hospitals, Ambulatory Surgical Centers (ASCs), and the broader health care sector H.R. 9392--Medicare Advantage Cost Transparency Act--An act to require MA plans and commercial plans to publicly post PA approval/denial rates, appeal outcomes, and average determination timelines H.R. 9395--Broker Compensation Bill--Statutory caps on compensation paid by MA organizations to agents and brokers H.R. 9544--Saving MEDICARE Act of 2026--To amend title XVIII of the Social Security Act to ensure appropriate payments under Medicare Advantage, and for other purposes. H.R. 8163--Provider Reimbursement Stability Act of 2026--Medicare physician payment reform and APM incentives H.R. 8375--Medicare Advantage Improvement Act--Prior authorization reform, plan transparency, prompt pay, and coverage standards alignment Issues related to data collection and sharing among health plans, providers, and community-based organizations issues Issues related to mental and behavioral health issues in Medicare Advantage Rural Network Adequacy Issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142623,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"M.","last_name":"LONG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":146278,"prefix":null,"prefix_display":null,"first_name":"JENNIFER","nickname":null,"middle_name":null,"last_name":"NORD MALLARD","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149563,"prefix":null,"prefix_display":null,"first_name":"MACKENZIE","nickname":null,"middle_name":null,"last_name":"BANKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/0fdd0703-9987-4144-9f40-a60c547de052/","filing_uuid":"0fdd0703-9987-4144-9f40-a60c547de052","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/0fdd0703-9987-4144-9f40-a60c547de052/print/","filing_document_content_type":"text/html","income":null,"expenses":"1100000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"James Schulz","dt_posted":"2026-07-28T10:21:50-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 C Street NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":2228,"url":"https://lda.gov/api/v1/registrants/2228/","house_registrant_id":31024,"name":"AMERICAN DENTAL ASSOCIATION","description":null,"address_1":"1111 14th Street NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES SCHULZ, JR.","contact_telephone":"+1 202-898-2400","dt_updated":"2026-08-10T14:22:55.429944-04:00"},"client":{"id":103538,"url":"https://lda.gov/api/v1/clients/103538/","client_id":12,"name":"AMERICAN DENTAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Implementation of the Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act of 2024 in the context of VA community care dental program, dental provider networks, and access to dental care for eligible veterans.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 9260, H.R. 9171, H.R. 8800, H.R. 8469 - FY27 appropriations for dentistry and oral health funding, including federal oral health prevention programs, dental research, NIH/NIDCR funding, VA funding, HRSA oral health workforce programs, CDC oral health activities, and Indian Health Service dental programs. Federal grant, research funding, and nonprofit funding policy affecting dental research institutions, dental schools, FQHCs, and oral health nonprofits, including OMB and NIH policy proposals affecting allowable costs, publishing costs, indirect costs, and federal research support.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Dental faculty pipeline impacts tied to immigration/H-1B policies affecting dental schools Implementation of changes to student aid programs put forth in the One Big Beautiful Bill Act of 2025 Efforts to make changes to eligibility requirements for the Public Service Loan Forgiveness (PSLF) Program. Teaching Health Center, GME, National Health Service Corps and Community Health Center reauthorization H.R. 2028/ S. 942 Resident Education Deferred Interest Act (REDI Act) H.R. 3711/S. 1948 Protecting Our Students by Terminating Graduate Rates that Add to Debt Act (POST GRAD Act) H.R. 3885, Community Training, Education, and Access for Medical Students Act of 2025 (Community TEAMS Act) H.R. 4262, To reauthorize programs related to health professions education ED-2025 Negotiated Rulemaking; William D. Ford Federal Direct Loan (Direct Loan) Program (90 FR 15665) (namely proposed changes to the Public Service Loan Forgiveness (PSLF) program)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false},{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":154,"name":"Bureau of Citizenship & Immigration Services (BCIS)"},{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicaid strengthening and public benefit policy, including adult dental benefits, pediatric dental/EPSDT protections, Medicaid financing, and Medicaid managed care. CMS Chief Dental Officer position in the Office of the Administrator CMS Rural Health Transformation Program guidance Implementation of changes to Medicaid programs put forth in the One Big Beautiful Bill Act of 2025 H.R. 5243, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage H.R. 9392, Medicare Advantage Cost Transparency Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Health care workforce expansion policy and improving outcomes in rural and health professional shortage areas S. 266/H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization S. 1101/H.R. 2332, the States Handling Access to Reciprocity for Employment (SHARE) Act S. 2954, Healthcare Workforce Expansion Act of 2025 S. 4370, the Primary Care Team Education Centers Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false},{"lobbyist":{"id":151623,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"ROSSETTO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":154,"name":"Bureau of Citizenship & Immigration Services (BCIS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Eligibility of oral health services and products as qualified medical expenses for reimbursement or payment through Flexible Spending Arrangements (FSAs) and Health Savings Accounts (HSAs); H.R. 1219, Oral Health Products Inclusion Act Tax policy affecting dental practices, small businesses, and health care providers, including implementation of tax provisions in the One Big Beautiful Bill Act of 2025, as applicable.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"CDC Office on Smoking and Health FY27 funding level and appropriations language","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"FY27 appropriations and policy support for Indian Health Service dental programs, oral health workforce, and access to dental care in tribal communities.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.R. 1800, National Defense Authorization Act provisions related to military dental treatment facilities, accreditation, military dental readiness, and TRICARE Dental Program policy, including Selected Reserve dental cost-sharing or fee provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Senate HELP Committee health care affordability input House Ways and Means and Senate Finance Committee submissions on rising health care costs, early prevention, oral health integration, strengthening public benefits for high-risk patients, team-based models, and reducing administrative barriers H.R. 6561, PREVENT HPV Cancers Act of 2025 H.R. 2001, Action for Dental Health Act Federal oral health infrastructure and public health policy, including oral health leadership and capacity across HHS agencies, cross-agency coordination, the relationship between oral health and mental health outcomes, and HRSA public health priorities relevant to oral health. H.R. 3409, HEADs UP Act H.R. 4556, Protect Our Treatment for Enamel, Erosion, and Tooth Health Act (Protect our TEETH Act) S. 4008, Promoting Dental Health Act House Energy and Commerce health care transparency legislation and related proposals, including itemized billing, provider disclosure, charity care, collections, surprise billing, and application of hospital-style requirements to dental offices. S. 4008, Promoting Dental Health Act EPA-Review of Science on Fluoride in Drinking Water: Preliminary Assessment Plan and Literature Survey (91 FR 3722) FDA-Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population (90 FR 25329) NIH-Request for Information on Maximizing Research Funds by Limiting Allowable Publishing Costs (NOT-OD-25-138) NIH-Request for Information (RFI): Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for Fiscal Years 2027-2031 (NOT-OD-26-047) NIH policy affecting dental and craniofacial research, including proposals related to limits on principal investigator grants and research funding stewardship. HHS/PACCARB policy concerning antimicrobial stewardship and the National Action Plan on Combating Antibiotic-Resistant Bacteria. HHS request for information on chronic disease of addiction, mental health, prevention, treatment, and recovery policy. HHS Section 1557 nondiscrimination implementation and notice of vacatur affecting covered health programs and activities. Teledentistry, direct-to-consumer dental/orthodontic treatment, and legislation or policy concerning in-person examination requirements before dental or orthodontic treatment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false},{"lobbyist":{"id":154830,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"WOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Medicare Advantage supplemental dental benefits, including benefit transparency, encounter data, marketing, beneficiary understanding of coverage, alignment of advertised benefits with actual coverage, consumer protections, surprise billing, provider directory accuracy, and oversight of dental benefit administration. CMS Notice of Benefit and Payment Parameters for 2027 and CMS RFI on the essential health benefits framework and typical employer standard, including pediatric oral health EHB, adult dental coverage, stand-alone dental plans, riders, carve-outs, and state flexibility.t H.R. 1521, Dental and Optometric Care (DOC) Access Act S. 1677/H.R. 3277, Ensuring Lasting Smiles Act (ELSA) S. 1164/H.R. 1397, Increasing Access to Dental Insurance Act H.R. 7931, Improving Dental Administration Act ERISA preemption and dental benefit plan accountability, including noncovered services, network leasing, assignment of benefits, virtual credit cards, prior authorization, retroactive denials, downcoding, prompt payment, and application of state dental insurance reforms to self-funded plans. H.R. 5582, Patients Deserve Price Tags Act H.R. 9177, Clear Healthcare Expense Cost Knowledge Act of 2026 H.R. 9397, Premium Transparency Act H.R. 9396, Prior Authorization Accountability Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152514,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs affecting dental medical devices, consumables, and PPE","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"Tariffs cost impacts on dental practices and the dental supply chain","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"HIPAA Security Rule, HIPAA Privacy Rule, cybersecurity compliance, and administrative burden for dental providers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"USCIS policy changes affecting H-1B visas and the dental education workforce","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151623,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"ROSSETTO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":154,"name":"Bureau of Citizenship & Immigration Services (BCIS)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/78dbd72f-c45e-41b7-a339-4a33002e6648/","filing_uuid":"78dbd72f-c45e-41b7-a339-4a33002e6648","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/78dbd72f-c45e-41b7-a339-4a33002e6648/print/","filing_document_content_type":"text/html","income":null,"expenses":"119057.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"George Lyons, Jr.","dt_posted":"2026-10-14T14:56:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"25 Massachusetts Avenue, NW, Suite 700","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":311451,"url":"https://lda.gov/api/v1/registrants/311451/","house_registrant_id":40002,"name":"AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC.","description":"Healthcare","address_1":"25 Massachusetts Avenue NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GEORGE LYONS JR.","contact_telephone":"+1 202-261-4531","dt_updated":"2026-07-13T14:54:36.424626-04:00"},"client":{"id":183820,"url":"https://lda.gov/api/v1/clients/183820/","client_id":12,"name":"AMERICAN COLLEGE OF PHYSICIAN SERVICES, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1999-12-30"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ACPSs 2026 Third Quarter Lobbying Disclosure Report Medicare Payments to Physicians: Sent letter and met with legislators in support of the Patients First Act of 2026, (H.R. 9693) for a Medicare Economic Index inflationary updated to the physician fee schedule for physician practices, support for independent practices and replacement of MIPS with POINTS for quality measures. Supported and urged Congress to pass (H.R. 8163, S.5180), the Provider Reimbursement Stability Act, to enhance Medicare reimbursement stability for physicians by modernizing the Medicare Physician Fee Schedule. The Provider Reimbursement Stability Act of 2026. H.R. 8163 would raise the budget neutrality threshold from $20 million to $57.64 million and would use cumulative increases in the Medicare Economic Index (MEI) to update the threshold every 5 years. ACP supported the Medicare Physician Data-Drive Performance Payment System Act of 2026, H.R. 8622. This critical legislation seeks to modernize Medicare payments by reducing administrative burdens, improving patient care, and supporting small/rural practices through a more practical, data-driven approach. Dr. William Fox, Chair Emeritus of ACPs Board of Regents, testified before the House Energy and Commerce Committees Health Subcommittee on policy reforms to improve the Medicare Physician Fee Schedule and the Medicare Access and CHIP Reauthorization Act (MACRA) on behalf of ACP. Dr. Rebecca Andrews, Past Chair of ACPs Board of Regents, testified before the House E&C Health Subcommittee in favor of each of the bills mentioned above. ACP supported Pay PCPs Act of 2026 (S. 5269), to inject $10 billion federal investment from fiscal year 2027 through 2031 to provide for the establishment of hybrid primary care payments under Medicare. Support Value-Based Care: Urged reintroduction and support of the Value in Health Care Act of 2024. The bill provides a multi-year commitment to reforming care delivery by extending MACRAs 5 percent advanced alternative payment models (APM) incentives that expired at the end of 2024. ACP supported the Preserving Patient Access to Accountable Care Act which aligns with Colleges policy to support the transition to value-based payments through alternative payment models (APMs) that can accommodate a wide range of specialties, practice sizes, and unique patient populations. ACP supported this legislation as it would extend the incentive payments for qualifying physicians and other clinicians to participate in Medicare advanced APMs through payment year 2027 at an increased amount of 3.53 percent and would freeze the scheduled increase in qualifying thresholds. Pricing Transparency/Consolidation: Provided comments to the House Energy and Commerce Committees markup, which includes the Lower Cost, More Transparency Act, H.R. 9393, and the Improving Seniors Timely Access to Care Act, H.R. 3514. The two bills would enhance price transparency across health care entities and streamline unnecessary administrative burden, respectively. ACP also supported several policies included in bills slated for markup that would reform Medicare Advantage practices to ensure accountability and safeguard market competition. ACP strongly supports pricing transparency in health care. ACP supported the passage of the Lower Costs, More Transparency Act, which passed the House in the 118th Congress, and we continue to support its reintroduction and passage in this Congress under H.R. 9393. ACP supported provisions within the Medicare Advantage Cost Transparency Act, H.R. 9392, led by Ranking Member DeGette and Dr. Joyce, which would provide greater oversight by requiring that Medicare Advantage (MA) plans report to the Centers for Medicare & Medicaid Services (CMS) on encounter data, including the allowed amount that a plan agreed to pay for a service in total and the total out-of-pocket costs the patient pays for a service. The College has repeatedly voiced support for the Improving Seniors' Timely Access to Care Act, led by Reps. Kelly and DelBene, which would protect patients from unnecessary delays in care and reduce administrative burden on physicians by streamlining MAs prior authorization approval processes. We urge Congress to pass H.R. 3514 to ensure that our patients will get the care they need, when they need it most. FY2026 Appropriations/Agency Restructuring: For FY2027, ACP is urged appropriations committees that funding be either maintained or increased for the following proven programs: 1) Health Resources Services Administration (HRSA), $10.5 billion, including: 2) Health Workforce, National Health Service Corps (NHSC), $915.6 million in total program funding; 3) Primary Care Training and Enhancement (PCTE), $71 million; 4) Title X Family Planning Program, $390 million; 5) Agency for Healthcare Research and Quality (AHRQ), $500 million; 6) Centers for Disease Control and Prevention (CDC) Injury Prevention and Control, $11.6 billion, including: 7) Firearm Injury and Mortality Prevention Research, $35 million; 8) Chronic Disease Prevention and Health Promotion, Social Determinants of Health, $100 million; 9) National Institutes of Health (NIH), $51.3 billion, including: 10) Office of the Director, Firearms Research, $25 million; 11) Centers for Medicare and Medicaid Services (CMS) and Government Accountability Office (GAO); and 12) Report language to ensure primary care physicians are receiving Medicare physician revaluations. We urged Congress to include report language in the FY2026 Labor HHS appropriations bill to direct the GAO to conduct a study encompassing the last decade of CMS estimates of new and revised code utilizations. ACP believes CMS has overestimated utilizations, thus adversely affecting available funds in the Medicare physician fee schedule for other code usage. While the House and Senate bills included language, we prefer the stronger House version language and hope Congress will pass the FY26 Labor HHS bills. Also urged Congress to include report language in the FY2027 Labor HHS appropriations bill directing a study on extent G2211 add on codes and increases in fee schedule for primary care are being retained by hiring entities (hospitals, ACOs, private equity) versus the physicians. ACP urged appropriators to provide $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health (NIH), and $1 million for the National Institute of Justice (NIJ) to conduct public health research into firearm morbidity and mortality prevention. Primary Care and the Physician Workforce: ACP urged Congress to support the Resident Physician Shortage Reduction Act of 2025 (S. 2439/ H.R. 4731), which would increase the number of Medicare supported direct graduate medical education (DGME) and indirect medical education (IME) positions by 14,000 over seven years. ACP supported the Conrad State 30 and Physician Access Reauthorization Act, S. 709 and H.R. 1585, to allow states to sponsor foreign-trained physicians to work in medically underserved areas in exchange for a waiver of the physicians' two-year foreign residence requirement. We supported the Resident Education Deferred Interest (REDI) Act (S 942/HR 2028) that, if passed, will allow borrowers to qualify for interest-free deferment on their student loans while serving in a medical or dental internship or residency program. ACP supported legislation for the H-1Bs for Physicians and Healthcare Workforce Act, H.R. 7961. The bill's primary goal is to exempt healthcare professionals from a $100,000 H-1B visa filing fee. ACP supported H.R. 8765, the Prioritizing Primary Care Act. This legislation would mandate an annual report on federal spending on primary care as well as establish a working group to study and make recommendations on how each federal agency addresses the issue. Scope of Practice: ACP provided comments urging the House Ways and Means Committee during markup to oppose the Equitable Community Access to Pharmacist Services Act, which would expand Medicare coverage to permanently include select services provided by a pharmacist. ACP advocated before Senate offices against the marked-up bill coming out of House Ways and Means and renamed the Main Street Pharmacy Access Act enabling pharmacists to bill certain Medicare codes and to diagnose and treat flu, strep throat and other respiratory infections. Expand Patient Access: We urged Congress to reintroduce and pass the Chronic Care Management Improvement Act. This legislation would have removed the cost sharing requirement for patients to access chronic care management services. We also support allowing the physician that performs chronic care management services to waive the requirement that the patient pay the 20 percent coinsurance fee associated with this service. We urged Congress to protect the public health infrastructure, recognize evidence-based science and preserve healthcare agency staffing to inform and protect the public from infectious disease and other health emergencies. Incidences of previously well-controlled, vaccine-preventable diseases, such as pertussis (whooping cough) and measles, are increasing in the United States. Vaccines are vital to our ability to prevent diseases that threaten public health, including novel diseases and future pandemics. We urged Congress to utilize the best possible scientific evidence to guide public health legislation. It is critical that public health leaders support evidence-based medicine, including the use of vaccines and other effective public health strategies that protect the public. ACP conducted a Hill Briefing on using scientifically driven, evidenced-based vaccines. Clinical Labs: Supported the provision in H.R. 6366 that would delay payment reductions and data reporting periods for the Clinical Laboratory Fee Schedule under the Protecting Access to Medicare Act (PAMA). Legislation could improve patient access to laboratory tests used to diagnose, monitor, prevent, and manage diseases for Medicare beneficiaries. Prescription Drug Reform: Supported the Capping Prescription Costs Act, introduced by Senator Raphael Warnock. The legislation would lower prescription drug costs for millions of Americans by placing annual caps on out-of-pocket costs for prescription drugs at $2,000 for individuals and $4,000 for families with private insurance. Supported bipartisan Drug-price Transparency for Consumers (DTC) Act, a bill that would require price disclosures on advertisements for prescription drugs in order to empower patients and reduce Americans colossal spending on medications. The bill was introduced by Senators Dick Durbin and Chuck Grassley. ACP also supported the Saving Seniors Money on Prescriptions Act, H.R. 950, which aims to drive down the rising costs of prescription drugs for patients on Medicare by improving price transparency in Pharmacy Benefit Managers (PBMs) business practices. Urged Congress to reintroduce and pass: 1) the Lowering Drug Costs for American Families Act, to expand the number of prescription drugs which Medicare can negotiate under the Inflation Reduction Act from 20 to 50 starting in 2029; 2) the Medicare PBM Accountability Act, legislation aimed at lowering the costs of prescription drugs for seniors covered by Medicare Part D and Medicare Advantage plans; 3) the Increasing Access to Biosimilars Act of 2023, legislation which would encourage adoption of biosimilars in Medicare and improve biosimilar accessibility, by establishing a new pilot program - a voluntary, shared savings demonstration program - for providers of biosimilars in Medicare Part B; 4) the Cutting Copays Act, legislation which would eliminate cost-sharing for generic drugs for LIS beneficiaries, helping to incentivize the use of generic drugs; and the Drug Shortage Prevention Act of 2023, which would require that manufacturers of over-the-counter and prescription drugs notify Food & Drug Administration when they are unlikely to meet demand. ACP supported legislation, Drug-Price Transparency for Consumers (DTC) Act, by Senators. Durbin and Grassley that requires Direct-to-Consumer advertisements for prescription drugs and biological products paid for by Medicare and Medicaid to include the list price or Wholesale Acquisition Cost (WAC) for a 30-month supply-which is the price set by manufacturers (and which is paid by uninsured patients, as well as the 50 percent of patients with high-deductible plans).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":37837,"prefix":null,"prefix_display":null,"first_name":"BRIAN","nickname":null,"middle_name":null,"last_name":"BUCKLEY","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":60177,"prefix":null,"prefix_display":null,"first_name":"JARED","nickname":null,"middle_name":null,"last_name":"FROST","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":104508,"prefix":null,"prefix_display":null,"first_name":"GEORGE","nickname":null,"middle_name":null,"last_name":"LYONS","suffix":"jr","suffix_display":"JR"},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":9,"name":"President of the U.S."},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/eab4438c-b170-4e2d-b0d6-7914bcb62ee3/","filing_uuid":"eab4438c-b170-4e2d-b0d6-7914bcb62ee3","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/eab4438c-b170-4e2d-b0d6-7914bcb62ee3/print/","filing_document_content_type":"text/html","income":null,"expenses":"86880.00","expenses_method":"B","expenses_method_display":"B","posted_by_name":"Shari Erickson","dt_posted":"2026-10-14T15:04:42-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"25 Massachusetts Avenue, NW, Suite 700","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"WASHINGTON","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":2002,"url":"https://lda.gov/api/v1/registrants/2002/","house_registrant_id":32190,"name":"AMERICAN COLLEGE OF PHYSICIANS","description":null,"address_1":"25 Massachusetts Avenue, NW, Suite 700","address_2":null,"address_3":null,"address_4":null,"city":"WASHINGTON","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"GEORGE LYONS JR.","contact_telephone":"+1 202-261-4531","dt_updated":"2026-07-13T17:53:37.650943-04:00"},"client":{"id":102673,"url":"https://lda.gov/api/v1/clients/102673/","client_id":12,"name":"AMERICAN COLLEGE OF PHYSICIANS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"ACPs 2026 Third Quarter Lobbying Disclosure Report Medicare Payments to Physicians: Sent letter and met with legislators in support of the Patients First Act of 2026, (H.R. 9693) for a Medicare Economic Index inflationary updated to the physician fee schedule for physician practices, support for independent practices and replacement of MIPS with POINTS for quality measures. Supported and urged Congress to pass (H.R. 8163, S.5180), the Provider Reimbursement Stability Act, to enhance Medicare reimbursement stability for physicians by modernizing the Medicare Physician Fee Schedule. The Provider Reimbursement Stability Act of 2026. H.R. 8163 would raise the budget neutrality threshold from $20 million to $57.64 million and would use cumulative increases in the Medicare Economic Index (MEI) to update the threshold every 5 years. ACP supported the Medicare Physician Data-Drive Performance Payment System Act of 2026, H.R. 8622. This critical legislation seeks to modernize Medicare payments by reducing administrative burdens, improving patient care, and supporting small/rural practices through a more practical, data-driven approach. Dr. William Fox, Chair Emeritus of ACPs Board of Regents, testified before the House Energy and Commerce Committees Health Subcommittee on policy reforms to improve the Medicare Physician Fee Schedule and the Medicare Access and CHIP Reauthorization Act (MACRA) on behalf of ACP. Dr. Rebecca Andrews, Past Chair of ACPs Board of Regents, testified before the House E&C Health Subcommittee in favor of each of the bills mentioned above. ACP supported Pay PCPs Act of 2026 (S. 5269), to inject $10 billion federal investment from fiscal year 2027 through 2031 to provide for the establishment of hybrid primary care payments under Medicare. Support Value-Based Care: Urged reintroduction and support of the Value in Health Care Act of 2024. The bill provides a multi-year commitment to reforming care delivery by extending MACRAs 5 percent advanced alternative payment models (APM) incentives that expired at the end of 2024. ACP supported the Preserving Patient Access to Accountable Care Act which aligns with Colleges policy to support the transition to value-based payments through alternative payment models (APMs) that can accommodate a wide range of specialties, practice sizes, and unique patient populations. ACP supported this legislation as it would extend the incentive payments for qualifying physicians and other clinicians to participate in Medicare advanced APMs through payment year 2027 at an increased amount of 3.53 percent and would freeze the scheduled increase in qualifying thresholds. Pricing Transparency/Consolidation: Provided comments to the House Energy and Commerce Committees markup, which includes the Lower Cost, More Transparency Act, H.R. 9393, and the Improving Seniors Timely Access to Care Act, H.R. 3514. The two bills would enhance price transparency across health care entities and streamline unnecessary administrative burden, respectively. ACP also supported several policies included in bills slated for markup that would reform Medicare Advantage practices to ensure accountability and safeguard market competition. ACP strongly supports pricing transparency in health care. ACP supported the passage of the Lower Costs, More Transparency Act, which passed the House in the 118th Congress, and we continue to support its reintroduction and passage in this Congress under H.R. 9393. ACP supported provisions within the Medicare Advantage Cost Transparency Act, H.R. 9392, led by Ranking Member DeGette and Dr. Joyce, which would provide greater oversight by requiring that Medicare Advantage (MA) plans report to the Centers for Medicare & Medicaid Services (CMS) on encounter data, including the allowed amount that a plan agreed to pay for a service in total and the total out-of-pocket costs the patient pays for a service. The College has repeatedly voiced support for the Improving Seniors' Timely Access to Care Act, led by Reps. Kelly and DelBene, which would protect patients from unnecessary delays in care and reduce administrative burden on physicians by streamlining MAs prior authorization approval processes. We urge Congress to pass H.R. 3514 to ensure that our patients will get the care they need, when they need it most. FY2026 Appropriations/Agency Restructuring: For FY2027, ACP is urged appropriations committees that funding be either maintained or increased for the following proven programs: 1) Health Resources Services Administration (HRSA), $10.5 billion, including: 2) Health Workforce, National Health Service Corps (NHSC), $915.6 million in total program funding; 3) Primary Care Training and Enhancement (PCTE), $71 million; 4) Title X Family Planning Program, $390 million; 5) Agency for Healthcare Research and Quality (AHRQ), $500 million; 6) Centers for Disease Control and Prevention (CDC) Injury Prevention and Control, $11.6 billion, including: 7) Firearm Injury and Mortality Prevention Research, $35 million; 8) Chronic Disease Prevention and Health Promotion, Social Determinants of Health, $100 million; 9) National Institutes of Health (NIH), $51.3 billion, including: 10) Office of the Director, Firearms Research, $25 million; 11) Centers for Medicare and Medicaid Services (CMS) and Government Accountability Office (GAO); and 12) Report language to ensure primary care physicians are receiving Medicare physician revaluations. We urged Congress to include report language in the FY2026 Labor HHS appropriations bill to direct the GAO to conduct a study encompassing the last decade of CMS estimates of new and revised code utilizations. ACP believes CMS has overestimated utilizations, thus adversely affecting available funds in the Medicare physician fee schedule for other code usage. While the House and Senate bills included language, we prefer the stronger House version language and hope Congress will pass the FY26 Labor HHS bills. Also urged Congress to include report language in the FY2027 Labor HHS appropriations bill directing a study on extent G2211 add on codes and increases in fee schedule for primary care are being retained by hiring entities (hospitals, ACOs, private equity) versus the physicians. ACP urged appropriators to provide $35 million for the U.S. Centers for Disease Control and Prevention (CDC), $25 million for the National Institutes of Health (NIH), and $1 million for the National Institute of Justice (NIJ) to conduct public health research into firearm morbidity and mortality prevention. Primary Care and the Physician Workforce: ACP urged Congress to support the Resident Physician Shortage Reduction Act of 2025 (S. 2439/ H.R. 4731), which would increase the number of Medicare supported direct graduate medical education (DGME) and indirect medical education (IME) positions by 14,000 over seven years. ACP supported the Conrad State 30 and Physician Access Reauthorization Act, S. 709 and H.R. 1585, to allow states to sponsor foreign-trained physicians to work in medically underserved areas in exchange for a waiver of the physicians' two-year foreign residence requirement. We supported the Resident Education Deferred Interest (REDI) Act (S 942/HR 2028) that, if passed, will allow borrowers to qualify for interest-free deferment on their student loans while serving in a medical or dental internship or residency program. ACP supported legislation for the H-1Bs for Physicians and Healthcare Workforce Act, H.R. 7961. The bill's primary goal is to exempt healthcare professionals from a $100,000 H-1B visa filing fee. ACP supported H.R. 8765, the Prioritizing Primary Care Act. This legislation would mandate an annual report on federal spending on primary care as well as establish a working group to study and make recommendations on how each federal agency addresses the issue. Scope of Practice: ACP provided comments urging the House Ways and Means Committee during markup to oppose the Equitable Community Access to Pharmacist Services Act, which would expand Medicare coverage to permanently include select services provided by a pharmacist. ACP advocated before Senate offices against the marked-up bill coming out of House Ways and Means and renamed the Main Street Pharmacy Access Act enabling pharmacists to bill certain Medicare codes and to diagnose and treat flu, strep throat and other respiratory infections. Expand Patient Access: We urged Congress to reintroduce and pass the Chronic Care Management Improvement Act. This legislation would have removed the cost sharing requirement for patients to access chronic care management services. We also support allowing the physician that performs chronic care management services to waive the requirement that the patient pay the 20 percent coinsurance fee associated with this service. We urged Congress to protect the public health infrastructure, recognize evidence-based science and preserve healthcare agency staffing to inform and protect the public from infectious disease and other health emergencies. Incidences of previously well-controlled, vaccine-preventable diseases, such as pertussis (whooping cough) and measles, are increasing in the United States. Vaccines are vital to our ability to prevent diseases that threaten public health, including novel diseases and future pandemics. We urged Congress to utilize the best possible scientific evidence to guide public health legislation. It is critical that public health leaders support evidence-based medicine, including the use of vaccines and other effective public health strategies that protect the public. ACP conducted a Hill Briefing on using scientifically driven, evidenced-based vaccines. Clinical Labs: Supported the provision in H.R. 6366 that would delay payment reductions and data reporting periods for the Clinical Laboratory Fee Schedule under the Protecting Access to Medicare Act (PAMA). Legislation could improve patient access to laboratory tests used to diagnose, monitor, prevent, and manage diseases for Medicare beneficiaries. Prescription Drug Reform: Supported the Capping Prescription Costs Act, introduced by Senator Raphael Warnock. The legislation would lower prescription drug costs for millions of Americans by placing annual caps on out-of-pocket costs for prescription drugs at $2,000 for individuals and $4,000 for families with private insurance. Supported bipartisan Drug-price Transparency for Consumers (DTC) Act, a bill that would require price disclosures on advertisements for prescription drugs in order to empower patients and reduce Americans colossal spending on medications. The bill was introduced by Senators Dick Durbin and Chuck Grassley. ACP also supported the Saving Seniors Money on Prescriptions Act, H.R. 950, which aims to drive down the rising costs of prescription drugs for patients on Medicare by improving price transparency in Pharmacy Benefit Managers (PBMs) business practices. Urged Congress to reintroduce and pass: 1) the Lowering Drug Costs for American Families Act, to expand the number of prescription drugs which Medicare can negotiate under the Inflation Reduction Act from 20 to 50 starting in 2029; 2) the Medicare PBM Accountability Act, legislation aimed at lowering the costs of prescription drugs for seniors covered by Medicare Part D and Medicare Advantage plans; 3) the Increasing Access to Biosimilars Act of 2023, legislation which would encourage adoption of biosimilars in Medicare and improve biosimilar accessibility, by establishing a new pilot program - a voluntary, shared savings demonstration program - for providers of biosimilars in Medicare Part B; 4) the Cutting Copays Act, legislation which would eliminate cost-sharing for generic drugs for LIS beneficiaries, helping to incentivize the use of generic drugs; and the Drug Shortage Prevention Act of 2023, which would require that manufacturers of over-the-counter and prescription drugs notify Food & Drug Administration when they are unlikely to meet demand. ACP supported legislation, Drug-Price Transparency for Consumers (DTC) Act, by Senators. Durbin and Grassley that requires Direct-to-Consumer advertisements for prescription drugs and biological products paid for by Medicare and Medicaid to include the list price or Wholesale Acquisition Cost (WAC) for a 30-month supply-which is the price set by manufacturers (and which is paid by uninsured patients, as well as the 50 percent of patients with high-deductible plans).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":53637,"prefix":null,"prefix_display":null,"first_name":"SHARI","nickname":null,"middle_name":null,"last_name":"ERICKSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":141127,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"PUGACH","suffix":null,"suffix_display":null},"covered_position":null,"new":true}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":201,"name":"Homeland Security, Dept of (DHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":9,"name":"President of the U.S."},{"id":1,"name":"SENATE"},{"id":39,"name":"State, Dept of (DOS)"},{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/492d17a3-9a97-4205-a305-bca77bafc360/","filing_uuid":"492d17a3-9a97-4205-a305-bca77bafc360","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/492d17a3-9a97-4205-a305-bca77bafc360/print/","filing_document_content_type":"text/html","income":null,"expenses":"670000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Alison Esquea","dt_posted":"2026-10-15T14:16:37-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"700 12th St NW","registrant_address_2":"Ste. 700","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401105208,"url":"https://lda.gov/api/v1/registrants/401105208/","house_registrant_id":null,"name":"CAMBIA HEALTH SOLUTIONS","description":"Innovative health care solutions","address_1":"601 13th St. NW, Ste. 900 South","address_2":null,"address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"ALISON ESQUEA","contact_telephone":"+1 202-253-5455","dt_updated":"2026-07-27T16:33:38.902734-04:00"},"client":{"id":203401,"url":"https://lda.gov/api/v1/clients/203401/","client_id":12,"name":"CAMBIA HEALTH SOLUTIONS","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2019-02-19"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordable Care Act and Extending Enhanced APTCs (H.R. 247; S. 46), Individual Market/ACA exchanges; Fraudulent Enrollments in Qualified Health Plans (S. 976, HR 2079), Behavioral Health, Employer-Provided Health Coverage; Surprise Billing (S. 2420, H.R. 4710); Cybersecurity; Health IT, Health Care Innovation, Transparency & PBMs (S. 891, H.R. 6703), PBM Compensation (H.R. 7895), Prescription Drugs (S. 1954, S. 1096, S.1040), Price Transparency (S. 2355, H.R. 9393, H.R. 9397, H.R. 9645, H.R. 9390), Prior Authorization (H.R. 9396), 340B, Insulin (S. 4189), Corporate Practice of Medicine, Anticompetitive Contracting (H.R. 6248, S. 4027).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70189,"prefix":null,"prefix_display":null,"first_name":"ALISON","nickname":null,"middle_name":null,"last_name":"ESQUEA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145155,"prefix":null,"prefix_display":null,"first_name":"RYNE","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":"Intern - Rep. Ed Perlmutter","new":false},{"lobbyist":{"id":153403,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"HRUBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage: Star Ratings, Risk Adjustment, Supplemental Benefits (H.R. 5746, H.R. 5243), No UPCODE Act (S. 1105), Medicare Prior Authorization and Electronic Prior Authorization (H.R. 3514, H.R. 8375), Provider Directories (S. 891), Telehealth Extending Flexibilities (H.R. 4206, S. 1261), Transparency & PBMs (S. 882; S. 891, S. 3345, H.R. 9392), Physician Fee Schedule, Site Neutrality (H.R. 7149), Broker/Agents (H.R. 9395), MLR (H.R. 9644).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70189,"prefix":null,"prefix_display":null,"first_name":"ALISON","nickname":null,"middle_name":null,"last_name":"ESQUEA","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":145155,"prefix":null,"prefix_display":null,"first_name":"RYNE","nickname":null,"middle_name":null,"last_name":"CARNEY","suffix":null,"suffix_display":null},"covered_position":"Intern - Rep. Ed Perlmutter","new":false},{"lobbyist":{"id":153403,"prefix":null,"prefix_display":null,"first_name":"MEGAN","nickname":null,"middle_name":null,"last_name":"HRUBY","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/ba5f1486-5cea-4409-8ad4-729a92dbd5a8/","filing_uuid":"ba5f1486-5cea-4409-8ad4-729a92dbd5a8","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/ba5f1486-5cea-4409-8ad4-729a92dbd5a8/print/","filing_document_content_type":"text/html","income":null,"expenses":"420000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Tavarski Hughes","dt_posted":"2026-10-19T13:23:36-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"240 Madison Avenue","registrant_address_2":null,"registrant_different_address":true,"registrant_city":"MEMPHIS","registrant_state":"TN","registrant_zip":"38103","registrant":{"id":6440,"url":"https://lda.gov/api/v1/registrants/6440/","house_registrant_id":33435,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","description":null,"address_1":"240 Madison Avenue","address_2":null,"address_3":null,"address_4":null,"city":"MEMPHIS","state":"TN","state_display":"Tennessee","zip":"38103","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"TAVARSKI HUGHES","contact_telephone":"+1 901-417-2486","dt_updated":"2026-07-18T18:34:35.847553-04:00"},"client":{"id":108763,"url":"https://lda.gov/api/v1/clients/108763/","client_id":12,"name":"BLUECROSS BLUESHIELD OF TENNESSEE","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"TN","state_display":"Tennessee","country":"US","country_display":"United States of America","ppb_state":"TN","ppb_state_display":"Tennessee","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-14"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordable Care Act (ACA), ACA subsidies and tax credits; Telehealth/telehealth flexibilities, ACA Fraud; Transparency in Coverage; Exchanges; Rural Healthcare; Prior Authorization (PA); Managed Care Organizations; Hospital Billing/Consolidation; Maternal Health; Employer Provided Health Coverage; Individual Marketplace Program Integrity; EAPTC Extension; HealthCare Affordability; Suprise Billing; Artificial Intelligence S.2355 - Patients Deserve Price Tags Act To amend the Public Health Service Act to provide for hospital and insurer price transparency. Sponsor: Sen. Roger Marshall H.R. 4710 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Rep Gergory Murphy S. 2420 - No Surprises Act Enforcement Act To amend title XXVII of the Public Health Service Act, the Employee Retirement Income Security Act of 1974, and the Internal Revenue Cide if 1986 to increase penalties for group health plans, health insurance issuers and nonparticipating providers or facilities for practices that violate balance billing requirements, and for other purposes. Sponsor: Sen. Roger Marshall S. 4027- Health Competition For Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Sen Jon Justed H.R. 6248 Healthy Competition for Better Care Act To ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care Sponsor: Rep Jodey Arrington H.R. 2079 - Insurance Fraud Accountability Act To amend the Patient Protection and Affordable Care Act to reduce fraudulent enrollments in qualified health plans, and for other purposes. H.R. 8684 - Transparency in Billing Act of 2026 To amend the Employee Retirement Income Security Act of 1974 to require group health plans and health insurance issuers offering group health insurance coverage to only pay claims submitted by hospitals that have in place policies and procedures to ensure accurate billing practices, and for other purposes. H.R. 9393 - Lower Costs, More Transparency Act of 2026 To promote price transparency in the health care sector S. 2301 - Improving Care in Rural Camerica Reauthorization Act of 2025 To reauthorize certain programs regarding rural health care.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicare Advantage (MA) and MA Rate Notice; Medicaid Cuts; Site Neutral Payment reform; MA Reform; Program Fraud Waste and Abuse; Durable Medical Equipment S. 1105 - No UPCODE Act To amend title XVIII of the Social Security Act to improve risk adjustment under Medicare Advantage H.R. 842 - Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests. Sponsor: Rep Jodey Arrington H.R. 9392 - Medicare Advantage Cost Transparency Act To amend title XVIII of the Social Security Act to require the inclusion of certain information in Medicare Advantage encounter data. H.R. 3514 - Improving Seniors Timely Access to Care Act of 2025 To amend Title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. H.R. 8871 - DME Scammer Prevention Act of 2026 To amend title XVIII of the Social Security Act to promote Medicare program integrity with respect to certain medical equipment and supplies. S. 3762 - Prior Authorization Relief Act To amend part C of the title XVIII of the Social Security Act to provide for prior authorization reforms under the Medicare Advantage program.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Pharmacy Benefit Managers Reform; Prescription Drug Cost; Delinking of Pharmacy; Generic Access; Direct to Consumer Marketing; Pay to Play; Patents S. 3014 - Ensuring Timely Access to Generics Act of 2025 To amend the Federal Food, Drug and Cosmetic Act with respect to citizen petitions. Sponsor: Sen. Jeanne Shaheen S.1040 - Drug Competition Enhancement Act A bill to amend the Federal Trade Commission Act to prohibit product hopping, and for other purposes. Sponsor: Sen. John Cornyn S.1095 - Stop STALLING Act A bill to enable the Federal Trade Commission to deter filing of sham citizen petitions to cover an attempt to interfere with approval of a competing generic drug or biosimilar, to foster competition and facilitate the effective review of petitions filed in good faith to raise legitimate public health concerns, and for other purposes. Sponsor: Sen Amy Klobuchar S. 1096 - Preserve Access to Affordable Generics and Biosimilars Act A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of o generic drug into the market, and to prohibit biological product manufacturers from compensating biosimilar and interchangeable companies to delay the entry of biosimilar biological products and interchangeable biological products. Sponsor: Sen Amy Klobuchar H.R. 4570 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: Rep Joe Neguse S1097 - Interagency Patent Coordination and Improvement Act of 2025 TO amend title 35, United States Code, to establish an interagency task force between the United States Patent and Trademark Office and the Food and Drug Administration for purposes of sharing information and providing technical assistance with respect to patents, and for other purposes. Sponsor: S. Richard Durbin","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":54810,"prefix":"mr","prefix_display":"MR.","first_name":"TAVARSKI","nickname":null,"middle_name":"D","last_name":"HUGHES","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/088f4ed8-b1b3-494f-92ee-6694d2aa1cf7/","filing_uuid":"088f4ed8-b1b3-494f-92ee-6694d2aa1cf7","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/088f4ed8-b1b3-494f-92ee-6694d2aa1cf7/print/","filing_document_content_type":"text/html","income":null,"expenses":"290000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Chris Long","dt_posted":"2026-10-20T15:37:46-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1425 K Street NW","registrant_address_2":"Suite 700","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20005","registrant":{"id":401104493,"url":"https://lda.gov/api/v1/registrants/401104493/","house_registrant_id":null,"name":"BETTER MEDICARE ALLIANCE, INC.","description":"Nonprofit supporting Medicare Advantage.","address_1":"1425 K Street NW","address_2":"Suite 700","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"CHRIS LONG","contact_telephone":"+1 202-735-0037","dt_updated":"2026-07-30T11:39:36.929227-04:00"},"client":{"id":201949,"url":"https://lda.gov/api/v1/clients/201949/","client_id":12,"name":"BETTER MEDICARE ALLIANCE, INC.","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2017-05-30"},"lobbying_activities":[{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"S. 2120--Older Americans Act Reauthorization Act of 2025--Reauthorizes through FY2030, modifies, and establishes programs under the Older Americans Act, which supports social services and activities for individuals aged 60 years or older. S.1105--No Unreasonable Payments, Coding, or Diagnoses for the Elderly (No UPCODE) Act--An act to improve the way Medicare Advantage plans assess patients health risks and reduce overpayments for care. H.R 4093--Apples to Apples--An act to require the Secretary of Health and Human Services to publish information on expenditures under the Medicare program, and for other purposes. S. 2625--Independent BROKERS TIME Act of 2025--An Act to carry out certain activities relating to the regulation of independent agents and brokers and third-party marketing organizations under parts C and D of the Medicare program, and for other purposes. H.R 5243--Increase data transparency for supplemental benefits under Medicare Advantage--An Act to increase data transparency around Medicare Advantage supplemental benefits for seniors. S. 2793--Require Medicare Advantage plans to cover items and services furnished by certain essential community providers within a service area--An act to add an Essential Community Provider (ECP) requirement to Medicare Advantage networks. H.R. 5454--Medicare Advantage Prompt Pay Act--An act to improve Medicare Advantages (MA) billing practices, offer certainty health care providers who contract with MA plans, and ensure that seniors arent stuck with unfair, confusing, or delayed bills after receiving critical care. HR 5746--Addressing Whole Health in Medicare Advantage Act--Supplemental Benefits for chronically Ill enrollees S. 3573--Medicare Advantage Supplemental Benefits Transparency Act--Improving Supplemental Benefits for MA beneficiaries HR 3514--To amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans--Prior Authorization in Medicare Advantage S 1816--A bill to amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans-Prior Authorization in Medicare Advantage H.R. 9393--Lower Costs, More Transparency Act of 2026--Promotes price transparency across hospitals, Ambulatory Surgical Centers (ASCs), and the broader health care sector H.R. 9392--Medicare Advantage Cost Transparency Act--An act to require MA plans and commercial plans to publicly post PA approval/denial rates, appeal outcomes, and average determination timelines H.R. 9395--Transparency in Medicare Advantage Steering Act--Statutory caps on compensation paid by MA organizations to agents and brokers H.R. 9544--Saving MEDICARE Act of 2026--To amend title XVIII of the Social Security Act to ensure appropriate payments under Medicare Advantage, and for other purposes. H.R.8163--Provider Reimbursement Stability Act of 2026--Medicare physician payment reform and Alternative Payment Model (APM) incentives H.R. 8375--Medicare Advantage Improvement Act--Prior authorization reform, plan transparency, prompt pay, and coverage standards alignment H.R. 9397--Premium Transparency Act--Requires MA plans to publish overhead costs, claims payment data, and MLR revenue detail H.R. 9396-Prior Authorization Accountability Act--Public posting of PA approval/denial rates, appeal outcomes, and processing times H.R. 9693--Patients First Act--Physician Fee Schedule reform H.R. 9645--Health Care Price Certainty for All Americans Act--Price transparency reform Health CARE Act of 2026--Reverse health care provisions from H.R. 1","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142623,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"M.","last_name":"LONG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149563,"prefix":null,"prefix_display":null,"first_name":"MACKENZIE","nickname":null,"middle_name":null,"last_name":"BANKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Payer provider directories and accuracy of information issues General Telemedicine Issues Issues related to data collection and sharing among health plans, providers, and community-based organizations issues Rural health issues","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":142623,"prefix":"mr","prefix_display":"MR.","first_name":"CHRISTOPHER","nickname":null,"middle_name":"M.","last_name":"LONG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149563,"prefix":null,"prefix_display":null,"first_name":"MACKENZIE","nickname":null,"middle_name":null,"last_name":"BANKS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/7d30efc5-4797-4159-9ba2-63ed6bf800af/","filing_uuid":"7d30efc5-4797-4159-9ba2-63ed6bf800af","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/7d30efc5-4797-4159-9ba2-63ed6bf800af/print/","filing_document_content_type":"text/html","income":null,"expenses":"300000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"Kenneth Lawrence","dt_posted":"2026-10-20T16:22:19-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"1800 CENTER STREET","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"CAMP HILL","registrant_state":"PA","registrant_zip":"17089","registrant":{"id":18238,"url":"https://lda.gov/api/v1/registrants/18238/","house_registrant_id":30976,"name":"HIGHMARK, INC.","description":null,"address_1":"1800 CENTER STREET","address_2":null,"address_3":null,"address_4":null,"city":"CAMP HILL","state":"PA","state_display":"Pennsylvania","zip":"17089","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"KENNETH LAWRENCE","contact_telephone":"+1 412-544-8910","dt_updated":"2026-07-29T10:27:26.376432-04:00"},"client":{"id":123583,"url":"https://lda.gov/api/v1/clients/123583/","client_id":12,"name":"HIGHMARK INC","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"PA","state_display":"Pennsylvania","country":"US","country_display":"United States of America","ppb_state":"PA","ppb_state_display":"Pennsylvania","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2007-08-08"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"PBM Reform, transparency S. 1414, Expedited Access to Biosimilars Act - A bill to provide that clinical studies required for licensure of biological products as biosimilar shall not be required to include the assessment of immunogenicity, pharmacodynamics, or comparative clinical efficacy. S.4189 - INSULIN Act of 2026 - A bill to reduce the price of insulin and provide for patient protections with respect to the cost of insulin. H.R.7895 - PBM Kickback Prohibition Act - A bill to prohibit kickbacks to pharmacy benefit managers.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":17810,"prefix":"mr","prefix_display":"MR.","first_name":"GREGORY","nickname":null,"middle_name":"P","last_name":"ENGLERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Affordability of Coverage, Site-Neutral Payments, Hospital Billing, Artificial Intelligence, Prior Authorization, Surprise Billing, Vertical Integration, Transparency, Anti-Steering/Tiering S.3822 - Break Up Big Medicine Act - A bill to prohibit pharmacy benefit managers, insurers, and prescription drug or medical device wholesalers from being under common ownership with certain medical service providers, and for other purposes. H.R. 5582/S.2355 - Patients Deserve Price Tags Act - A bill to provide for hospital and insurer price transparency. H.R. 6248/S.4027 - Healthy Competition for Better Care Act - A bill to ban anticompetitive terms in facility and insurance contracts that limit access to higher quality, lower cost care. H.R.4710 - No Surprises Act Enforcement Act - A bill to increase penalties for group health plans and health insurance issuers for practices that violate balance billing requirements, and for other purposes. H.R. 9393, Lower Costs, More Transparency Act - A bill to require group health plans, individual market issuers, PBMs, hospitals, clinical laboratories, imaging service providers, and ambulatory surgical centers, to publicly disclose pricing and other specified information. H.R.9396 - Prior Authorization Accountability Act - A bill to require the displaying of claim denial rates. H.R.9397 - Premium Transparency Act - A bill to ensure health insurer accountability through publishing of overhead costs and claim payments, and to direct the Secretary of Health and Human Services to issue guidance on the provision of certain insurance information. H.R.9645 - Health Care Price Certainty for All Americans Act - A bill To promote health care price transparency, and for other purposes.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":17810,"prefix":"mr","prefix_display":"MR.","first_name":"GREGORY","nickname":null,"middle_name":"P","last_name":"ENGLERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicaid Reform Implementation, Medicare Advantage, Risk Adjustment, Star Ratings, Prior Authorization, Site Neutral Payments, Prompt Pay, Provider Directories, Transparency H.R.8375 - Medicare Advantage Improvement Act of 2026 - A bill to provide for certain reforms under the Medicare Advantage program, and for other purposes. S. 1105 - No Unreasonable Payments, Coding, Or Diagnoses for the Elderly Act (No UPCODE) Act - This bill modifies certain factors that are used to determine Medicare Advantage (MA) payments, particularly relating to health status and related data. H.R. 4077/S. 2145 - GUARD Veterans Health Care Act - To amend title 38, United States Code, and the Social Security Act to permit recovery from the Department of Veterans Affairs of costs from Medicare Advantage and Medicare prescription drug plans and to modify the authority for recovery by the United States of reasonable charges for certain care or services furnished to veterans for non-service-connected disabilities, and for other purposes. H.R. 3514/S. 1816 - Improving Seniors Timely Access to Care Act of 2025 - To amend title XVIII of the Social Security Act to establish requirements with respect to the use of prior authorization under Medicare Advantage plans. S. 3848/H.R. 4093 - Apples to Apples Comparison Act of 2025 - to require the Secretary of Health and Human Services to publish information on expenditures under the Medicare program, and for other purposes. H.R.5243 - A bill to increase data transparency for supplemental benefits under Medicare Advantage. H.R. 9392, Medicare Advantage Cost Transparency Act - A bill to require MA plans to report specified information on encounter data submitted to CMS. H.R. 9395, Transparency in Medicare Advantage Steering Act - Requires MA plans to annually identify individuals enrolled by an agent, broker or other third-party and report information about compensation paid.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":17810,"prefix":"mr","prefix_display":"MR.","first_name":"GREGORY","nickname":null,"middle_name":"P","last_name":"ENGLERT","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]},{"url":"https://lda.gov/api/v1/filings/9fe28ebd-639a-428b-bcdd-e9c1d32d7e0f/","filing_uuid":"9fe28ebd-639a-428b-bcdd-e9c1d32d7e0f","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2026,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.gov/filings/public/filing/9fe28ebd-639a-428b-bcdd-e9c1d32d7e0f/print/","filing_document_content_type":"text/html","income":null,"expenses":"210000.00","expenses_method":"A","expenses_method_display":"A","posted_by_name":"James Schulz","dt_posted":"2026-10-20T16:36:06-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"400 C Street NE","registrant_address_2":null,"registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20002","registrant":{"id":2228,"url":"https://lda.gov/api/v1/registrants/2228/","house_registrant_id":31024,"name":"AMERICAN DENTAL ASSOCIATION","description":null,"address_1":"1111 14th Street NW","address_2":"Suite 1100","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20005","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"JAMES SCHULZ, JR.","contact_telephone":"+1 202-898-2400","dt_updated":"2026-08-10T14:22:55.429944-04:00"},"client":{"id":103538,"url":"https://lda.gov/api/v1/clients/103538/","client_id":12,"name":"AMERICAN DENTAL ASSOCIATION","general_description":null,"client_government_entity":false,"client_self_select":true,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"DC","ppb_state_display":"District of Columbia","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"1996-02-14"},"lobbying_activities":[{"general_issue_code":"TRD","general_issue_code_display":"Trade (domestic/foreign)","description":"Tariffs affecting dental medical devices, consumables, and personal protective equipment.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"}]},{"general_issue_code":"SMB","general_issue_code_display":"Small Business","description":"Tariffs cost impacts on dental practices and the dental supply chain","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":24,"name":"Commerce, Dept of (DOC)"}]},{"general_issue_code":"BUD","general_issue_code_display":"Budget/Appropriations","description":"H.R. 9260, H.R. 9171, H.R. 8800, H.R. 8469, H.R. 6500 - FY27 appropriations for dentistry and oral health funding, including federal oral health prevention programs, military dental research, NIH/NIDCR funding, VA funding, HRSA oral health workforce programs, CDC oral health activities, and Indian Health Service dental programs. Federal grant, research funding, and nonprofit funding policy affecting dental research institutions, dental schools, FQHCs, and oral health nonprofits, including OMB and NIH policy proposals affecting allowable costs, publishing costs, indirect costs, and federal research support.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"EDU","general_issue_code_display":"Education","description":"Dental faculty pipeline impacts tied to immigration/H-1B policies affecting dental schools Implementation of changes to student aid programs put forth in the One Big Beautiful Bill Act of 2025 Efforts to make changes to eligibility requirements for the Public Service Loan Forgiveness (PSLF) Program. Teaching Health Center, GME, National Health Service Corps and Community Health Center reauthorization H.R. 2028/ S. 942 Resident Education Deferred Interest Act (REDI Act) H.R. 3711/S. 1948 Protecting Our Students by Terminating Graduate Rates that Add to Debt Act (POST GRAD Act) H.R. 3885, Community Training, Education, and Access for Medical Students Act of 2025 (Community TEAMS Act) H.R. 4262, To reauthorize programs related to health professions education ED-2025 Negotiated Rulemaking; William D. Ford Federal Direct Loan (Direct Loan) Program (90 FR 15665) (namely proposed changes to the Public Service Loan Forgiveness (PSLF) program) ED-Accreditation, Innovation, and Modernization: The Secretary's Recognition of Accrediting Agencies: Institutional Eligibility Under the Higher Education Act of 1965, as Amended, Student Assistance General Provisions (91 FR 53940)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false}],"government_entities":[{"id":154,"name":"Bureau of Citizenship & Immigration Services (BCIS)"},{"id":32,"name":"Education, Dept of"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"MMM","general_issue_code_display":"Medicare/Medicaid","description":"Medicaid strengthening and public benefit policy, including adult dental benefits, pediatric dental/EPSDT protections, Medicaid financing, and Medicaid managed care. CMS Chief Dental Officer position in the Office of the Administrator CMS Rural Health Transformation Program guidance Implementation of changes to Medicaid programs put forth in the One Big Beautiful Bill Act of 2025 H.R. 5243, To amend title XVIII of the Social Security Act to increase data transparency for supplemental benefits under Medicare Advantage H.R. 9392, Medicare Advantage Cost Transparency Act S. 5091/H.R.9831, Medicaid Dental Benefit Act of 2026","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"LBR","general_issue_code_display":"Labor Issues/Antitrust/Workplace","description":"Health care workforce expansion policy and improving outcomes in rural and health professional shortage areas S. 266/H.R. 929, Dr. Lorna Breen Health Care Provider Protection Reauthorization S. 1101/H.R. 2332, the States Handling Access to Reciprocity for Employment (SHARE) Act S. 2954, Healthcare Workforce Expansion Act of 2025 S. 4370, the Primary Care Team Education Centers Act S. 4110/H.R.4262, the EMPOWER for Health Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false},{"lobbyist":{"id":151623,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"ROSSETTO","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":154,"name":"Bureau of Citizenship & Immigration Services (BCIS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":38,"name":"Labor, Dept of (DOL)"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TAX","general_issue_code_display":"Taxation/Internal Revenue Code","description":"Eligibility of oral health services and products as qualified medical expenses for reimbursement or payment through Flexible Spending Arrangements (FSAs) and Health Savings Accounts (HSAs); H.R. 1219, Oral Health Products Inclusion Act Tax policy affecting dental practices, small businesses, and health care providers, including implementation of tax provisions in the One Big Beautiful Bill Act of 2025, as applicable.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"TOB","general_issue_code_display":"Tobacco","description":"H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (CDC Office on Smoking and Health)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"IND","general_issue_code_display":"Indian/Native American Affairs","description":"Support for Indian Health Service dental programs, oral health workforce, and access to dental care in tribal communities. H.R.9260 - Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027 (Indian Health Service)","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":138,"name":"Indian Health Service"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"DEF","general_issue_code_display":"Defense","description":"H.R.8800, the National Defense Authorization Act for Fiscal Year 2027 NDAA provisions related to military dental treatment facilities, accreditation, military dental readiness, and TRICARE Dental Program policy, including Selected Reserve dental cost-sharing or fee provisions.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":25,"name":"Defense, Dept of (DOD)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Senate HELP Committee health care affordability input House Ways and Means and Senate Finance Committee submissions on rising health care costs, early prevention, oral health integration, strengthening public benefits for high-risk patients, team-based models, and reducing administrative barriers H.R. 6561, PREVENT HPV Cancers Act of 2025 S. 5099/H.R. 2001, Action for Dental Health Act Federal oral health infrastructure and public health policy, including oral health leadership and capacity across HHS agencies, cross-agency coordination, the relationship between oral health and mental health outcomes, and HRSA public health priorities relevant to oral health. H.R. 3409, HEADs UP Act H.R. 4556, Protect Our Treatment for Enamel, Erosion, and Tooth Health Act (Protect our TEETH Act) S. 4008, Promoting Dental Health Act House Energy and Commerce health care transparency legislation and related proposals, including itemized billing, provider disclosure, charity care, collections, surprise billing, and application of hospital-style requirements to dental offices. EPA-Review of Science on Fluoride in Drinking Water: Preliminary Assessment Plan and Literature Survey (91 FR 3722) FDA-Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population (90 FR 25329) NIH-Request for Information on Maximizing Research Funds by Limiting Allowable Publishing Costs (NOT-OD-25-138) NIH-Request for Information (RFI): Inviting Comments and Suggestions on a Framework for the NIH-Wide Strategic Plan for Fiscal Years 2027-2031 (NOT-OD-26-047) NIH policy affecting dental and craniofacial research, including proposals related to limits on principal investigator grants and research funding stewardship. HHS/PACCARB policy concerning antimicrobial stewardship and the National Action Plan on Combating Antibiotic-Resistant Bacteria. HHS request for information on chronic disease of addiction, mental health, prevention, treatment, and recovery policy. HHS Section 1557 nondiscrimination implementation and notice of vacatur affecting covered health programs and activities. Teledentistry, direct-to-consumer dental/orthodontic treatment, and legislation or policy concerning in-person examination requirements before dental or orthodontic treatment. H.R. 9829, the ORTHO Act Issues concerning vertical integration and provider autonomy","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":23891,"prefix":"ms","prefix_display":"MS.","first_name":"JENNIFER","nickname":null,"middle_name":"MICHELLE","last_name":"FISHER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":149396,"prefix":null,"prefix_display":null,"first_name":"NICHOLAS","nickname":null,"middle_name":null,"last_name":"CARGAS","suffix":null,"suffix_display":null},"covered_position":"Rep. David Scott (09/2019-02/2025) Deputy Chief of Staff Legislative Assistant Legislative Correspondent Staff Assistant/Legislative Correspondent Staff Assistant Intern","new":false},{"lobbyist":{"id":154830,"prefix":null,"prefix_display":null,"first_name":"JEFFREY","nickname":null,"middle_name":null,"last_name":"WOOD","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":134,"name":"Centers For Disease Control & Prevention (CDC)"},{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":11,"name":"Executive Office of the President (EOP)"},{"id":135,"name":"Food & Drug Administration (FDA)"},{"id":137,"name":"Health Resources & Services Administration (HRSA)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"INS","general_issue_code_display":"Insurance","description":"Medicare Advantage supplemental dental benefits, including benefit transparency, encounter data, marketing, beneficiary understanding of coverage, alignment of advertised benefits with actual coverage, consumer protections, surprise billing, provider directory accuracy, and oversight of dental benefit administration. CMS Notice of Benefit and Payment Parameters for 2027 and CMS RFI on the essential health benefits framework and typical employer standard, including pediatric oral health EHB, adult dental coverage, stand-alone dental plans, riders, carve-outs, and state flexibility. ERISA preemption and dental benefit plan accountability, including noncovered services, network leasing, assignment of benefits, virtual credit cards, prior authorization, retroactive denials, downcoding, prompt payment, and application of state dental insurance reforms to self-funded plans. H.R. 1521, Dental and Optometric Care (DOC) Access Act S. 1677/H.R. 3277, Ensuring Lasting Smiles Act (ELSA) S. 1164/H.R. 1397, Increasing Access to Dental Insurance Act H.R. 7931, Improving Dental Administration Act S. 2355/H.R. 5582, Patients Deserve Price Tags Act H.R. 9117, Clear Healthcare Expense Cost Knowledge Act of 2026 H.R. 9397, Premium Transparency Act H.R. 9396, Prior Authorization Accountability Act S. 5088/H.R.9833, Ensuring Kids Have Access to Medically Necessary Dental Care Act Senate Finance Committee submission to improve coverage across the individual, employer and public insurance markets","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":67475,"prefix":null,"prefix_display":null,"first_name":"NATALIE","nickname":null,"middle_name":null,"last_name":"HALES","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":147937,"prefix":null,"prefix_display":null,"first_name":"JAMES","nickname":null,"middle_name":null,"last_name":"SCHULZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":152514,"prefix":null,"prefix_display":null,"first_name":"CHAD","nickname":null,"middle_name":null,"last_name":"OLSON","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"SCI","general_issue_code_display":"Science/Technology","description":"HIPAA Security Rule, HIPAA Privacy Rule, cybersecurity compliance, and administrative burden for dental providers. Federal health IT policy affecting dentistry, including ASTP/ONC interoperability and information blocking frameworks as applied to dental electronic health records, phased implementation expectations for small practices, and alignment with national data standards (including vendor accountability and enforcement focus on software vendors versus providers). CMS Interoperability Standards and Prior Authorization for Drugs proposed rule, CMS-0062-P, including electronic prior authorization, standards, APIs, HIPAA transaction policy, and provider burden.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":9422,"prefix":null,"prefix_display":null,"first_name":"ROBERT","nickname":"BOB","middle_name":null,"last_name":"BURNS","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"}]},{"general_issue_code":"IMM","general_issue_code_display":"Immigration","description":"USCIS policy changes affecting H-1B visas and the dental education workforce","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":151623,"prefix":null,"prefix_display":null,"first_name":"MATTHEW","nickname":null,"middle_name":null,"last_name":"ROSSETTO","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":154,"name":"Bureau of Citizenship & Immigration Services (BCIS)"}]},{"general_issue_code":"VET","general_issue_code_display":"Veterans","description":"Implementation of the Senator Elizabeth Dole 21st Century Veterans Healthcare and Benefits Improvement Act of 2024 in the context of VA community care dental program, dental provider networks, and access to dental care for eligible veterans. H.R. 210, the Dental Care for Veterans Act H.R. 10419, the Supporting Mobile and Integrated Local Examinations for Veterans Act","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":73041,"prefix":null,"prefix_display":null,"first_name":"DAVID","nickname":null,"middle_name":null,"last_name":"LINN","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":42,"name":"Veterans Affairs, Dept of (VA)"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}]}